Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Popular Biotech News, Healthcare News and Pharma News

09:22 EDT 20th April 2014 | BioPortfolio

RM3 - The New Red Mountain Weight Loss Program That Is Poised To Change The Industry

RM3 is an exclusive Red Mountain Weight Loss 3-Step comprehensive program, designed to help patients lose weight faster and help sustain their weight loss over time. Phoenix, AZ (PRWEB) March 01, 2014 On Saturday, March 1st, 2014, Red Mountain Weight Loss launched the new Weight Loss Program, RM3. RM3 is an exclusive 3-Step comprehensive program, designed to help patients lose weight faster and h...

Robin McGraw Launches When Georgia Smiled: The Robin McGraw Revelation Foundation

LOS ANGELES, Oct. 7, 2013 /PRNewswire/ -- Robin McGraw, two-time New York Times bestselling author, television personality and lifelong philanthropist, proudly announces the launch of When Georgia Smiled, a 501(c)(3) non-profit organization. The foundation's mission is to create and advance programs that help women and children, especially those affected by domestic violence, live healthy, sa...

Panaseeda: Review Examines Andreas Wecker and Activation Products' Panaseeda Five Oil Blend for Whole Body Health

Las Vegas, NV (PRWEB) October 26, 2013 'Panaseeda Five Oil Blend', an organic seed oil that aims at whole body health and is specifically designed to elevate one's health to never before seen levels, has caught the attention of Shane M...

Research Report on Fast Food Global Industry Analysis Trends And Forecast, 2013 - 2019

Transparency Market Research Report added "Research Report on Fast Food Global Industry Analysis Trends And Forecast, 2013 - 2019" to its database. Browse full report: http://www.transparencymarketresearch.com/fast-food-market.html. Albany, New York, USA (PRWEB) April 19, 2014 Transparency Market Research Reports included a detailed market survey and analysis trends on “Fast Food Mark...

New Research Report on Antidepressants Market to 2018 by MarketResearchReports

Albany, NY, February 24, 2013 --(PR.com)-- Antidepressants Market to 2018 Despite Safety Concerns, Selective Serotonin Re-uptake Inhibitors (SSRIs) Continue to Dominate in the Absence of Effective Therapeutic Alternatives GBI Research, the leading business intelligence provider, has released its latest research, Antidepressants Market to 2018 Despite Safety Concerns, Selective Serotonin Re-uptak...

Novo Solutions MD announces releases of NovoScarMD scar cream

Novo Solutions MD announces the launch of NovoScarMD the most scientifically advanced scar cream to come to market in 10 years. NovoScarMD reverses existing and new scar damage, keloids, and stretch marks, and rapidly returns skin to its original sta...

A Neurosurgeon’s Guide to Infectious Disease

New York, NY, August 18, 2013 --(PR.com)-- "Neurosurgical Infectious Disease: Surgical and Nonsurgical Management," by Walter A. Hall, MD and Peter D. Kim, MD, recently published by Thieme, is a comprehensive guide that gives surgeons the core knowledge they need to diagnose, treat, and prevent infectious diseases of the central nervous system. It emphasizes newer surgical techniques, i...

Live Continuing Medical Education (CME) 2014 Conference Dates and Locations for Primary Care and Family Medicine Released by Continuing Education Company Inc.

Continuing Education Company Inc. has released their live Continuing Medical Education (CME) conference dates and locations for the first part of 2014. These CME meetings focus on medical education for primary care, family physicians and internal medicine physicians, physician assistants and nurse practitioners. Palm Coast, Florida (PRWEB) September 19, 2013 Continuing Education Company Inc. has...

Differential diagnosis of a palmar and plantar rash

bmj;347/sep19_1/f5542/FIG1F1fig1A 35 year old man presented with a five day history of fever, cough, rash, and sore throat. He had conjunctivitis and a widespread maculopapular rash on his palms and...

FDA grants Roche ALK inhibitor alectinib breakthrough status

To obtain the breakthrough therapy designation, preliminary clinical evidence must indicate the experimental drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial...

LabCorp's HCV GenoSure NS3/4 test now available for Q80K polymorphism screening

Laboratory Corporation of America Holdings announced today the immediate availability of an enhanced version of its HCV GenoSure NS3/4, a drug resistance test that screens for the Q80K polymorphism. Q80K is a naturally occurring polymorphism that dev...

Brain shape different in former cannabis users

"Teenagers who smoke cannabis have 'poor memory and abnormal brain structures'," the Daily Mail reports. The headline accurately reflects the results of a small study looking at the effect of cannabis use on brain structure. Researchers compared the results of brain scans and tests of working memory from people who once had a "cannabis use disorder" with those from people...

Tisch MS Research Center of New York Exceeds $300K Crowdfunding Target for FDA-Approved Stem Cell Trial

Crowdfunding Gets FDA-Approved Stem Cell Trial Off To Fast Start New York, NY (PRWEB) April 15, 2014 The Tisch MS Research Center of New York (Tisch MSRCNY) today announced that they surpassed their campaign goal on Indiegogo.com to raise funds for their FDA-Approved Phase I Clinical Stem Cell Trial. The funding will be directly applied to the study and stem cell research at Tisch MSRCNY. The tar...

Hengrui Eyes International Expansion Amid Slowing Home Market

Sustained price cuts and an ongoing compliance probe have slowed down domestic market growth, effectively pushing the Chinese domestic drug maker to venture out to the U.S., European markets and Japan.

Louisville Dentists Says Denture Wearers Can Have Permanent Teeth Again

Louisville dentist Dr. Ronald Receveur is urging residents of Southern Indiana and the Greater Louisville, Ky., who are preparing for a summer wedding to consider planning their All on Four dental implants now to have them ready in time. Many of his past patients with false teeth have wanted their new teeth in time of a son's or daughter's wedding, as well to no longer needing to hold back...

Pfizer and BMS Score Approval for Orthopedic Drug

The European Commission has approved apixaban (Eliquis), developed by Pfizer and Bristol-Myers Squibb, for the prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery, according to a press release. The two New York companies have an alliance to develop the drug, which is a new oral direct [...]

GE Healthcare Life Sciences launches Capto Core 700 chromatography medium for viruses and other large biomolecules

High productivity alternative to group separation for intermediate purification and polishing,  offering higher sample loads and flow rates than gel filtration April 2nd 2012: GE Healthcare’s Capto Core 700 is a multimodal chromatography medium (resin) designed for intermediate purification and polishing of viruses and other large biomolecules. Capto Core 700 offers a range of pe...

OncoEthix In-Licenses OTX015, an anticancer Bromodomain inhibitor from Mitsubishi Tanabe Pharma Corporation

Lausanne, Switzerland, June 15 - OncoEthix, a Swiss-based company specializing in oncology drug development, has in-licensed a compound, OTX015, from Mitsubishi Tanabe Pharma Corporation (MTPC).  OTX015 is a synthetic small molecule targeted to BET bromodomains 2/3/4 (BRD2/3/4). Recent scientific publications have shown that inhibition of BRD2/3/4 down-regulates MYC transcription, fol...

GE Healthcare Life Sciences launches IN Cell Analyzer 2200 for super-fast and sensitive high-content cell imaging

Flexible and efficient cell imaging system for a broad range of high-content analysis assays   December 14th 2012: GE Healthcare’s IN Cell Analyzer 2200 is a high-speed, flexible, modular imaging system suitable for both investigative microscopy and automated high-content screening of organelles, cells, tissues and whole organisms. The IN Cell Analyzer 2200 can be configured to...

FDA delays approval of Dynavax' Heplisav, issuing CRL

Dynavax Technologies ( Nasdaq: DVAX) saw its shares plunge as much as 38% to $1.84 in pre-market trading on February 25, when the firm revealed that it received a Complete Response Letter (CRL) from the US. Food and Drug Administration regarding its...

Spironolactone Disappoints in Preserved-EF HF: Aldo-DHF

Aldosterone blockade didn't produce the outcomes that matter most to patients, despite one benefit in the 422-patient study that was at least encouraging. A large mortality trial is on the way. Heartwire

7 Pillars of a Successful Compliance Program

Rigorous exclusion monitoring sets the stage for a comprehensive program.

MusclePharm launches new line of supplements for women

MusclePharm, a nutritional supplement company, has introduced a new line of branded fitness supplements FitMiss for women with active lifestyles.

ENCO Pharmaceutical Development Announces Another Successful FDA Inspection - Its 2nd This Year

JACKSONVILLE, Fla., March 20, 2013 /PRNewswire-iReach/ --  ENCO Pharmaceutical Development's Jacksonville, FL Facility Completes Successful FDA Audit ENCO Pharmaceutical Development, Inc. (EPDI) is pleased to announce the completion of a successful FDA inspection of its Jacksonville FL facility.  The audit was a directed Pre-approval Inspection (PAI).  The audit occurred bet...

Enrollment in Gilead's ION-1 study continues following planned DSMB review

US HIVAIDS and antiviral drugs specialist Gilead Sciences (Nasdaq: GILD) has provided a positive update on ION-1, a Phase III clinical trial evaluating a once-daily fixed-dose combination of the nucleotide sofosbuvir and the NS5A inhibitor ledipasvir...

SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine

The Sir2 family of enzymes or sirtuins are known as nicotinamide adenine dinucleotide (NAD)-dependent deacetylases and have been implicated in the regulation of transcription, genome stability, metabolism and lifespan. However, four of the seven mamm...

RecordFlow Moves Into New Corporate Office in Santa Ana, CA

Santa Ana, CA, May 12, 2013 --(PR.com)-- RecordFlow will move into its new corporate headquarters location in Santa Ana on May 13th, 2013. The move from their prior location in Tustin, CA stems from a need for more office space due to the company’s continued growth and success. Akash Patel, CEO of RecordFlow said of the move, “We are excited for the transition to our new location as w...

Correction: Biogen Idec Says FDA Accepts BLA For Marketing Approval Of ELOCTATE

WESTON (dpa-AFX) - correction: corrects the headline to say the FDA has accepted the BLA, not approved.Biogen Idec Inc. (BIIB), a developer and marketer of therapies for the treatment of neurodege...

Coulter Client Ehlers-Danlos National Foundation to Open Research Clinic in Baltimore

EDNF to fund first ever EDNF Center for Clinical Care & Research McLean, VA (PRWEB) May 14, 2013 Coulter client, Ehlers-Danlos National Foundation (EDNF) will provide funding to support a virtual center at Greater Baltimore Medical Center (GBMC) under the direction of Clair Francomano, MD, GBMC's Director of Adult Genetics. The Center will provide comprehensive clinical care for patients,...

River Region Human Services Opens Counseling Center in Baker County

River Region Human Services has opened a Baker County location to provide mental health and substance abuse treatment. Macclenny, FL (PRWEB) May 15, 2013 River Region Human Services is now providing mental health and substance abuse counseling and treatment in Baker County. The new office is located at 56 North 2nd Street in Macclenny, FL and is open Monday through Friday from 8 a.m. to 5 p.m. Th...

Abutment-Free Sophono Systems Produce Comparable Study Results to Cochlear’s Baha Products, With Fewer Complications

Implantable Hearing Device Improves Children’s Hearing, Speech Understanding. Boulder, CO (PRWEB) May 21, 2013 Children using the abutment-free implantable bone conduction hearing device from Sophono, Inc., experience audiological results comparable to the traditionally used, competitive abutment device – and with many fewer complications, according to a new study. “The results are yet anot...

Poliovirus vaccine study shows encouraging results in glioblastoma patients

An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.

Boy With Longest ECMO Record Gets New Heart

A 6-year-old boy broke the record for surviving the longest on an ECMO machine that acted as his heart and lungs. He surpassed the odds and has now successfully received a heart transplant.

Tom Kleeman, MD Launches MDfitness, The Doctor’s Workout

After studying exercise and physiology in clinical practice for over 35 years, Dr. Kleeman and his wife Anne created MDfitness. Anne’s extensive experience in the health and fitness industry and deep-rooted passion for total well-being drove the couple to create a program for men and women over age 45, much like themselves, who want to feel 10 years younger. Bedford, NH (PRWEB) June 12, 2013 To...

Why lack of sleep is bad for your health

Why lack of sleep is bad for your healthMany effects of a lack of sleep, such as feeling grumpy and not working at your best, are well known. But did you know that sleep deprivation can also have profound consequences for your physical health? When you might need more sleep than normalThere are some situations when you'll need more than the standard eight hours of sleep a night. It’s not unusual...

Slide Show: Updated MERS-CoV Guidelines

The CDC has updated guidance for clinicians related to the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). New research indicates MERS-CoV spreads easily in healthcare settings.

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

Obesity has become more prevalent in most developed countries over the past few decades, and is increasingly recognized as a major risk factor for several common types of cancer. As the worldwide obesity epidemic has shown no signs of abating, better...

Sebring Cancer Center Welcomes Radiation Oncologist Dr. Michael Wing to the Practice

Sebring Cancer Center, of Sebring, Florida, announces the arrival of board-certified Radiation Oncologist, Dr. Michael Wing. Dr. Wing looks forward to joining the community and working with local physicians to deliver compassionate care to our patients. Sebring, FL (PRWEB) July 13, 2013 The physicians and staff of Sebring Cancer Center (SCC) of Sebring are proud to welcome Dr. Michael Wing, board...

GSK pulls Japan Relvar filing for COPD but asthma use on track

The once-daily product, developed with Theravance and which pairs the corticosteroid fluticasone furoate with vilanterol trifenatate, a long-acting beta2 agonist, was filed in Japan last September for the treatment of both asthma and chronic obstruct...

Original USP Labs Jack3D is Now Exclusively Available at Supplement Edge

USP Labs announces the release of Jack3D Micro, a new and improved variation on an old theme, Jack3D. (PRWEB) July 22, 2013 USP Labs announces the release of Jack3D Micro, a new and improved variation on an old theme, Jack3D. Jack3D Micro steps up its energy potential with the brand new micro formula which pushes a gym buff’s workout routine to a drastically improved level. As one of the most i...

Defactinib in Combination with Weekly Paclitaxel Achieves a Complete Response in Platinum-Resistant Ovarian Cancer

Interim results from an ongoing Phase 1/1b trial of VS-6063 (defactinib) in combination with weekly paclitaxel Verastem, Inc. (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced the confirmation of a complete response in an ongoing trial of VS-6063 (defactinib) in com...

A Race to Save the Orange by Altering Its DNA -- Amy Harmon

Amy Harmon at the NYT:CLEWISTON, Fla. — The call Ricke Kress and every other citrus grower in Florida dreaded came while he was driving.“It’s here” was all his grove manager needed to say to force him over to the side of the road.The disease that sours oranges and leaves them half green, already ravaging citrus crops across the world, had reached the state’s storied groves. Mr. Kress, th...

Pharmaceutical and vaccine industries combine lobbying power in New Zealand

The pharmaceutical and vaccine industry bodies, Medicines New Zealand and the Vaccines Industry Association of New Zealand, are merging to combine their lobbying prowess.

Monthly paliperidone among new Japan recommendations

The preliminary clearance is set to alter the dynamics of a large market for atypical antipsychotics where the company launched the standard oral preparations of the drug as Invega in late 2010. The long-acting injectable version was approved in the...

AZD8330: Development discontinued

Upsher-Smith Receives Tentative NDA Approval for Vogelxo™ (testosterone) Gel CIII

MAPLE GROVE, Minn., Aug. 16, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., today announced that it has received tentative approval from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Vogelxo™ (testosterone) gel for topical use CIII.    (Logo: http://photos.prnewswire.com/prnh/20130520/NY17281LOGO ) About Upsher-Smith  Upsher-...

DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Latest Defense Motion in Federal DePuy ASR Recall Litigation

The Firm is representing hundreds of DePuy ASR lawsuit plaintiffs who have suffered severe complications, including metallosis and premature device failure, related to the August 2010 DePuy ASR recall. New York, New York (PRWEB) August 21, 2013 The federal multidistrict litigation established for DePuy ASR hip lawsuits (http://www.depuy-asr-hip-recall.com/) continues to move towards the commence...

Transvaginal Mesh Lawsuit Update: Rottenstein Law Group LLP Comments on Bard Mesh Trial Settlement in W. Va.

The firm is currently offering Bard transvaginal mesh lawsuit evaluations to women who allege they sustained injuries from transvaginal mesh implants. (PRWEB) August 21, 2013 The second federal bellwether CR Bard transvaginal mesh trial ended after two days in a settlement between plaintiff Wanda Queen and the mesh maker for an undisclosed sum, according to an Aug. 21 Bloomberg story. The Rottens...

Search BioPortfolio: